Cornelia Lass‐Flörl
Impact in
- Infectious Diseases top 0.01%
- Antifungal resistance and susceptibility
- Epidemiology top 0.05%
- Fungal Infections and Studies
- Pneumocystis jirovecii pneumonia detection and treatment
- Nail Diseases and Treatments
Papers in
-
- Antifungal resistance and susceptibility 346
- Epidemiology 273
- Fungal Infections and Studies 235
- Pneumocystis jirovecii pneumonia detection and treatment 38
- Nail Diseases and Treatments 34
- Co-authors
- Maiken Cavling Arendrup (29 shared papers)Manuel Cuenca‐Estrella (22 shared papers)Malcolm Richardson (8 shared papers)Astrid Mayr (26 shared papers)Cornelia Speth (52 shared papers)Michaela Lackner (49 shared papers)William Hope (11 shared papers)Oliver A. Cornely (28 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (46 papers)Mycoses (36 papers)Clinical Microbiology and Infection (31 papers)Journal of Fungi (26 papers)Journal of Antimicrobial Chemotherapy (20 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Cornelia Lass‐Flörl
455 papers receiving 18.4k citations
Cornelia Lass‐Flörl's Hit Papers
Peers
Comparison fields: 5 of 167
- Infectious Diseases 14.1k
- Epidemiology 11.0k
- Small Animals 1.8k
- Applied Microbiology and Biotechnology 385
- Cell Biology 2.5k
Countries citing papers authored by Cornelia Lass‐Flörl
This map shows the geographic impact of Cornelia Lass‐Flörl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelia Lass‐Flörl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelia Lass‐Flörl more than expected).
Fields of papers citing papers by Cornelia Lass‐Flörl
This network shows the impact of papers produced by Cornelia Lass‐Flörl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelia Lass‐Flörl. The network helps show where Cornelia Lass‐Flörl may publish in the future.
Co-authors
The 25 scholars most cited alongside Cornelia Lass‐Flörl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 466 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts Hit paper breakdown → | 2008 | 549 |
| 2 | Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007 Hit paper breakdown → | 2011 | 540 |
| 3 | ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients Hit paper breakdown → | 2016 | 432 |
| 4 | 2008 | 385 | |
| 5 | EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST) Hit paper breakdown → | 2012 | 384 |
| 6 | 2010 | 346 | |
| 7 | Challenges in the diagnosis and treatment of mucormycosis Hit paper breakdown → | 2017 | 329 |
| 8 | Antifungal drug resistance among Candida species: mechanisms and clinical impact Hit paper breakdown → | 2015 | 316 |
| 9 | 2009 | 296 | |
| 10 | The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin Hit paper breakdown → | 2021 | 283 |
| 11 | 2020 | 278 | |
| 12 | 2011 | 241 | |
| 13 | 2005 | 213 | |
| 14 | 2011 | 211 | |
| 15 | 2007 | 208 | |
| 16 | 2011 | 206 | |
| 17 | 2010 | 194 | |
| 18 | 1998 | 183 | |
| 19 | 2020 | 182 | |
| 20 | 2007 | 176 |
About Cornelia Lass‐Flörl
Cornelia Lass‐Flörl is a scholar working on Infectious Diseases, Epidemiology, Cell Biology, Small Animals and Pharmacology, having authored 466 papers that have together received 18.8k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (346 papers), Fungal Infections and Studies (235 papers), Plant Pathogens and Fungal Diseases (65 papers), Infectious Diseases and Mycology (53 papers), Pneumocystis jirovecii pneumonia detection and treatment (38 papers), Nail Diseases and Treatments (34 papers), Fungal Biology and Applications (33 papers) and Mycotoxins in Agriculture and Food (29 papers). The work is most often cited by research in Infectious Diseases (14.1k citations), Epidemiology (11.0k citations), Small Animals (1.8k citations), Applied Microbiology and Biotechnology (385 citations) and Cell Biology (2.5k citations). Cornelia Lass‐Flörl has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Maiken Cavling Arendrup, Manuel Cuenca‐Estrella, Malcolm Richardson, Astrid Mayr, Cornelia Speth, Michaela Lackner, William Hope, Oliver A. Cornely, Susanne Perkhofer and Manfred P. Dierich. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Mycoses, Clinical Microbiology and Infection, Journal of Fungi and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.